Potential impacts red dye No. 3 has on children
May 2nd 2023In this Contemporary Pediatrics® interview, Jamie Alan, RPh, PharmD, PhD, associate professor, Department of Pharmacology and Toxicology, Michigan State University, talks about the potential impacts red dye No. 3 has on children, and why an assembly bill in California is trying to eliminate it.
FDA approves 20-valent pneumococcal conjugate vaccine for infants 6 weeks and older
April 28th 2023According to Pfizer, the company’s pneumococcal conjugate vaccine Prevnar 20 has been approved by the FDA to treat infants and children aged 6 weeks to 17 years for the prevention of invasive pneumococcal disease (IPD).
Emapalumab induces remission of macrophage activation syndrome
April 27th 2023According to a phase 2 study, remission of macrophage activation syndrome (MAS) secondary to systemic juvenile idiopathic arthritis (sJIA) or adult-onset Still’s disease (AOSD) was achieved in patients taking emapalumab who failed high-dose glucocorticoids.
Electrical nerve field stimulation leads to IBS symptom improvement of pediatric patients
April 25th 2023In addition, 17 female patients who completed PENFS showed improvements in various symptoms, such as pain, disability, and catastrophizing, while carbohydrate degradation and LCFA synthesis pathways decreased in the post-treatment and follow-up analysis.
Suspected self-poisoning suicide attempts skyrocket during pandemic
April 21st 2023Suspected self-poisoning suicide attempts increased 73% for children aged 10 to 12 years and 30% for those aged 10 to 19 years in 2021 compared to 2019, according to a Morbidity and Mortality Weekly Report (MMWR) from the CDC.
Discussing historic pediatric medical breakthroughs
April 17th 2023Andrew Lam, MD, retinal surgeon, author, assistant professor, University of Massachusetts Medical School explains what readers can look forward to in his new book, "The Masters of Medicine: Our Greatest Triumphs in the Race to Cure Humanity’s Deadliest Diseases."